[{"author":"TruthGundlach","content":"History will remember the post-debate \u201cuproar\u201d after DJT said his accepting the 2016 election result \u201cwould depend\u201d.  Prescient President.","pubdate":"20200127013849","NumFavorite":114,"NumShare":17,"CrawlerDate":20200720},{"author":"TruthGundlach","content":"I think a great many people will remember where they were the moment they heard Kobe Bryant had died.  I know I will.  Greatness.","pubdate":"20200127021617","NumFavorite":933,"NumShare":77,"CrawlerDate":20200720},{"author":"KerrisdaleCap","content":"Our first short of 2020 is $PRNB. Report avail at https:\/\/t.co\/IJcQcOl1eA. Conf call at 1pm: 866-834-3313, #8778858\u2026 https:\/\/t.co\/82rxity2WK","pubdate":"20200127144448","NumFavorite":32,"NumShare":13,"CrawlerDate":20200720},{"author":"KerrisdaleCap","content":"Celgene, Gilead, Lilly, and more have all tested BTKi's for autoimmune disorders, but it keeps failing. Why? BTK is\u2026 https:\/\/t.co\/mqDfh1auZW","pubdate":"20200127144510","NumFavorite":5,"NumShare":1,"CrawlerDate":20200720},{"author":"KerrisdaleCap","content":"$PRNB clinical data so far includes no placebo groups, and most of the patients keep taking other drugs (which are\u2026 https:\/\/t.co\/pSfC5I9wtU","pubdate":"20200127144539","NumFavorite":4,"NumShare":1,"CrawlerDate":20200720},{"author":"KerrisdaleCap","content":"In pemphigus and ITP, $PRNB\u2019s drug seems far inferior to the standard of care. Rituxan shows 90% complete-remission\u2026 https:\/\/t.co\/BAC6ID0VuW","pubdate":"20200127144622","NumFavorite":5,"NumShare":1,"CrawlerDate":20200720},{"author":"KerrisdaleCap","content":"$PRNB bulls are now hoping for good data in MS, but the trial is engineered to be messy and inconclusive. In realit\u2026 https:\/\/t.co\/cfLNtOJx8C","pubdate":"20200127144649","NumFavorite":6,"NumShare":1,"CrawlerDate":20200720},{"author":"KerrisdaleCap","content":"Serious safety risks loom for $PRNB too. BTKi's have serious on-target side effects, especially susceptibility to i\u2026 https:\/\/t.co\/STHWmGMGOU","pubdate":"20200127144742","NumFavorite":7,"NumShare":1,"CrawlerDate":20200720},{"author":"KerrisdaleCap","content":"$PRNB: Some additional background from another skeptic: https:\/\/t.co\/WkReomrwY1\nhttps:\/\/t.co\/h96XCnGQjR https:\/\/t.co\/vIEjFcb4gE","pubdate":"20200127153749","NumFavorite":6,"NumShare":2,"CrawlerDate":20200720},{"author":"KerrisdaleCap","content":"@ATLanalyst Remember, Sanofi has an established MS drug (Aubagio) facing near-term exclusivity loss (2023), while f\u2026 https:\/\/t.co\/tLAK58lwnm","pubdate":"20200127154812","NumFavorite":3,"NumShare":0,"CrawlerDate":20200720},{"author":"PresciencePoint","content":"Friday night filing reveals @Medallia's CEO unloaded another &gt;10% tranche of his stock. Since our report and the IP\u2026 https:\/\/t.co\/KNmEvaJGpH","pubdate":"20200127160424","NumFavorite":4,"NumShare":2,"CrawlerDate":20200720},{"author":"KerrisdaleCap","content":"RT @JohnCendpts: $PRNB $SNY\nShort attacker Sahm Adrangi draws crosshairs over a favorite of Sanofi\u2019s new CEO \u2014 with PhII data looming\nhttps\u2026","pubdate":"20200127162345","NumFavorite":0,"NumShare":3,"CrawlerDate":20200720},{"author":"KerrisdaleCap","content":"@ATLanalyst Sure, they might. But the question is whether drug really works &amp; what its place in the market would ev\u2026 https:\/\/t.co\/r3zf4T8hPC","pubdate":"20200127164025","NumFavorite":2,"NumShare":0,"CrawlerDate":20200720},{"author":"KerrisdaleCap","content":"$PRNB: productive call just ended, will provide replay tomorrow https:\/\/t.co\/KQlWXmdABB","pubdate":"20200127190427","NumFavorite":8,"NumShare":1,"CrawlerDate":20200720},{"author":"KerrisdaleCap","content":"RT @JohnCendpts: P.S. to my Sahm Adrangi story on $PRNB, I asked $BMY about BMS-986142, their BTKi which had quietly sunk below the waves.\u2026","pubdate":"20200127193946","NumFavorite":0,"NumShare":3,"CrawlerDate":20200720}]